IRAK4 Regulates NF-κB signaling to suppress CD8 + T cell activity and promote immune evasion in glioblastoma development

Key Points

• IRAK4 significantly regulates the activity of CD8+ T cells, leading to a promotion of immune evasion.
• The study highlights the role of NF-κB signaling pathways in glioblastoma progression.
• Assessment of immune responses in glioblastoma suggests that IRAK4 might be a therapeutic target.
• These findings emphasize the potential for novel interventions against glioblastoma by modulating immune pathways.